DrugPipeline.net has announced the addition of “Anticoagulants Market in the Us 2016 - 2020” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 05/30/2016 --Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles.

The 1990s saw rapid development in the field of direct thrombin inhibitors. Though these drugs, such as hirudin, have been in use from the early 19th century, they were accepted with the development of genetic engineering technology. The recombinant forms, such as desirudin, are also available in the market. During the same period, the focus shifted toward the development of factor Xa inhibitors, and by early 2000s, the first indirect factor Xa inhibitor, fondaparinux, was released into the market. These drugs were administered by parenteral route.

Report forecast the anti-coagulants market in the US to grow at a CAGR of 6.67% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the anti-coagulants market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generics drugs used to treat coagulation disorders. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market.

Anti-Coagulants Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Johnson & Johnson
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Sanofi
- Daiichi Sankyo

Other prominent vendors
- Armatheon Inc.
- Aspen
- AstraZeneca
- Bayer
- Cellceutix
- Cosmo Pharmaceuticals SA
- CSL Behring, Eisai, GSK
- Marathon Pharmaceuticals LLC
- Ockham Biotech
- Perosphere
- Portola Pharmaceuticals
- Sagent Pharmaceuticals Inc.
- The Medicines Company
- Urigen Pharmaceuticals Inc.
- Valeant Pharmaceuticals

Market driver
- Growing prevalence of coagulation disorders
- For a full, detailed list, view our report

Market challenge
- Side-effects associated with drugs
- For a full, detailed list, view our report

Market trend
- Expected exploitation of new therapeutic use
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 89 pages and 56 Exhibits "Anticoagulants Market in the Us 2016 - 2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Anticoagulants: An overview, Reimbursement scenario, Anticoagulant reversal agents, Approved anticoagulants in US, Anticoagulants pipeline portfolio, Market landscape, Market segmentation by ROA, Market segmentation by drug class, Market segmentation by application, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/anticoagulants-market-us-2016-2020

Related Reports:

Global Pneumatic Nebulizers Market 2016-2020 - Visit at - http://www.drugpipeline.net/technavio/global-pneumatic-nebulizers-market-2016-2020

Global Osteoarthritis Pain Market 2016-2020 - Visit at - http://www.drugpipeline.net/technavio/global-osteoarthritis-pain-market-2016-2020

Global Regenerative Medicine Market 2016-2020 - Visit at - http://www.drugpipeline.net/technavio/global-regenerative-medicine-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.